إعلان
إعلان
MCRB
Seres Therapeutics, Inc.
15.29
USDبرعاية
-0.16
-1.04%
٠٩ يناير, ١٠:٥٤ UTC -5
مفتوح
تقارير أرباح MCRB
النسبة الإيجابية المفاجئة
MCRB تفوق 19 من 40 آخر التقديرات.
48%
التقرير التالي
بيانات التقرير القادم
١١ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$2.17
التغير الضمني من Q3 25 (Revenue/ EPS)
-100.00%
/-330.85%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/+8.50%
Seres Therapeutics, Inc. earnings per share and revenue
On ٠٥ نوفمبر ٢٠٢٥, MCRB reported earnings of 0.94 USD per share (EPS) for Q3 25, missing the estimate of 1.30 USD, resulting in a -28.00% surprise. Revenue reached 351.00 ألف, compared to an expected --, with a 0.00% difference. The market reacted with a -7.64% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -2.17 USD, with revenue projected to reach -- USD, implying an نقصان of -330.85% EPS, and نقصان of -100.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Seres Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Seres Therapeutics, Inc. reported EPS of $0.94, missing estimates by -28%, and revenue of $351.00K, 0% as expectations.
How did the market react to Seres Therapeutics, Inc.'s Q3 2025 earnings?
The stock price moved down -7.64%, changed from $13.75 before the earnings release to $12.70 the day after.
When is Seres Therapeutics, Inc. expected to report next?
The next earning report is scheduled for ١١ مارس ٢٠٢٦.
What are the forecasts for Seres Therapeutics, Inc.'s next earnings report?
Based on 5
المحللين, Seres Therapeutics, Inc. is expected to report EPS of -$2.17 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان